Biosynthesis of the N-benzoyl phenylisoserinoyl side chain of the anticancer drug Taxol starts with the conversion of 2S-␣-phenylalanine to 3R--phenylalanine by phenylalanine aminomutase (PAM). A gene cloning approach was based on the assumption that PAM would resemble the well known plant enzyme phenylalanine ammonia lyase. A phenylalanine ammonia lyase-like sequence acquired from a Taxus cuspidata cDNA library was expressed functionally in Escherichia coli and confirmed as the target aminomutase that is virtually identical to the recombinant enzyme and clone from Taxus The final stages of Taxol biosynthesis (see Fig. 1A) in yew species involve the assembly and attachment to C-13 of the taxane core of the N-benzoyl phenylisoserinoyl side chain, which is an important pharmacophoric descriptor of this anticancer drug (1, 2). In the current practice of Taxol production, this side chain is attached by chemical semisynthesis to baccatin III, which is derived from 10-deacetylbaccatin III, a Taxus (yew) metabolite that is much more readily available than Taxol itself (3-5). In the biosynthetic pathway, five steps are involved in the construction of the side chain. The first step is considered to be the conversion of 2S-␣-phenylalanine to 3R--phenylalanine by an aminomutase that catalyzes an intramolecular migration of the amino group and a partial internal transfer of the pro-3S hydrogen (6, 7). This step is seemingly followed by the ligase-mediated activation to the corresponding CoA ester and then the transfer of -phenylalanoyl to the C-13 hydroxyl of baccatin III. The resulting intermediate (designated -phenylalanoyl baccatin III or N-debenzoyl-2Ј-deoxytaxol) then likely undergoes cytochrome P450-mediated hydroxylation at the side chain 2Ј-position to generate the isoserinoyl moiety and final N-benzoylation of this side chain (8) to complete the biosynthesis of Taxol. cDNAs encoding the two transferases involved in C-13 side chain assembly have been described previously (8,9).The relative abundance of -phenylalanine and side chaindeficient late pathway metabolites such as baccatin III and 10-deacetylbaccatin III in vivo (10) suggests that either the CoA ligase for -phenylalanine or the CoA ester-dependent -phenylalanoyltransferase (9), both of which function downstream of the aminomutase, may be rate limiting in side chain assembly and, thus, in Taxol biosynthesis. Because the phenylalanine aminomutase (PAM) 1 catalyzes the first step of the side chain assembly process and shares its primary metabolite substrate, phenylalanine, with several competing, non-taxoid phenylpropanoid pathway enzymes in plants (11-13), it is therefore an important target for genetic engineering in yew or derived cell cultures to increase Taxol production yields. PAM is also of interest enzymologically because the reaction that is catalyzed is unusual, and, in addition to the adenosylcobalamin-dependent leucine 2,3-aminomutase from Andrographis paniculata and potato tubers (14 -16), it is the only other aminomutase of plant origin d...